Gene · 3131
Papers1,870
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,870
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The mechanism of ferroptosis and its related diseases. | Mol Biomed | 2023 | 37840106 | PubTator, text mining | PubMed |
| MYCN Amplifications and Metabolic Rewiring in Neuroblastoma. | Cancers (Basel) | 2023 | 37835497 | PubTator, text mining | PubMed |
| Cost-effectiveness of decellularised bone allograft compared with fresh-frozen bone allograft for acetabular impaction bone grafting during a revision hip arthroplasty in the UK. | BMJ Open | 2023 | 37802609 | PubTator, text mining | PubMed |
| Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment. | Eur J Pharm Sci | 2023 | 37742986 | PubTator, text mining | PubMed |
| Green synthesis, characterization, anti-SARS-CoV-2 entry, and replication of lactoferrin-coated zinc nanoparticles with halting lung fibrosis induced in adult male albino rats. | Sci Rep | 2023 | 37741872 | PubTator, text mining | PubMed |
| Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancer. | J Transl Med | 2023 | 37735483 | PubTator, text mining | PubMed |
| The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG. | Nat Commun | 2023 | 37735473 | PubTator, text mining | PubMed |
| Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery. | Bioconjug Chem | 2023 | 37733627 | PubTator, text mining | PubMed |
| Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment. | Front Aging Neurosci | 2023 | 37731953 | PubTator, text mining | PubMed |
| Circadian clock and temporal meal pattern. | Med Rev (2021) | 2023 | 37724110 | PubTator, text mining | PubMed |
| Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer. | Mutagenesis | 2023 | 37712764 | PubTator, text mining | PubMed |
| HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway. | Cell Death Dis | 2023 | 37709768 | PubTator, text mining | PubMed |
| Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2023 | 37686604 | PubTator, text mining | PubMed |
| Tear Biomarkers and Alzheimer's Disease. | Int J Mol Sci | 2023 | 37686235 | PubTator, text mining | PubMed |
| Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities. | Diagnostics (Basel) | 2023 | 37685286 | PubTator, text mining | PubMed |
| Adverse Crosstalk between Extracellular Matrix Remodeling and Ferroptosis in Basal Breast Cancer. | Cells | 2023 | 37681908 | PubTator, text mining | PubMed |
| Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia. | Genes Dev | 2023 | 37673459 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37657044 | PubTator, text mining | PubMed |
| The immunomodulatory effects of lactoferrin and its derived peptides on NF-κB signaling pathway: A systematic review and meta-analysis. | Immun Inflamm Dis | 2023 | 37647433 | PubTator, text mining | PubMed |
| Recent advances in targeted strategies for triple-negative breast cancer. | J Hematol Oncol | 2023 | 37641116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3131/papers?page=7